A TNF-α related peptide W9 inhibits the soluble RANKL-induced osteoclastogenesis stronger than the membrane-bound RANKL-induced osteoclast formation

被引：0
|
作者：
Aoki, K
Suzuki, Y
Horie, D
Ohya, K
机构：
[1] Tokyo Med & Dent Univ, Grad Sch, Pharmacol Sect, Tokyo 1138549, Japan
[2] Tokyo Med & Dent Univ, Grad Sch, Sect Periodontol, Tokyo 1138549, Japan
来源：
JAPANESE JOURNAL OF PHARMACOLOGY | 2002年 / 88卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
P183
引用
收藏
页码：107P / 107P
页数：1
相关论文
共 50 条
  • [31] RANKL-induced expression of tetraspanin CD9 in lipid raft membrane microdomain is essential for cell fusion during osteoclastogenesis
    Ishii, M
    Iwai, K
    Koike, M
    Ohshima, S
    Kudo-Tanaka, E
    Ishii, T
    Mima, T
    Katada, Y
    Miyatake, K
    Uchiyama, Y
    Saeki, Y
    JOURNAL OF BONE AND MINERAL RESEARCH, 2006, 21 (06) : 965 - 976
  • [32] Cajaninstilbene acid inhibits osteoporosis through suppressing osteoclast formation and RANKL-induced signaling pathways (vol 234, pg 11792, 2019)
    Sun, Youqiang
    Liu, Yuhao
    He, Wei
    Wang, Chao
    Tickner, Jennifer
    Kuek, Vincent
    Zhou, Chi
    Wang, Haibin
    Zou, Xuting
    Hong, Zhinan
    Yang, Fan
    Shao, Min
    Chen, Leilei
    Xu, Jiake
    JOURNAL OF CELLULAR PHYSIOLOGY, 2020, 235 (7-8) : 5862 - 5862
  • [33] FNDC4 Inhibits RANKL-Induced Osteoclast Formation by Suppressing NF-κB Activation and CXCL10 Expression
    Lv, Zheng-Tao
    Liang, Shuang
    Chen, Kun
    Zhang, Jia-Ming
    Cheng, Peng
    Guo, Jia-Chao
    Yang, Qing
    Zhou, Chen-He
    Liao, Hui
    Chen, An-Min
    BIOMED RESEARCH INTERNATIONAL, 2018, 2018
  • [34] Sanguinarine inhibits osteoclast formation and bone resorption via suppressing RANKL-induced activation of NF-κB and ERK signaling pathways
    Li, Haowei
    Zhai, Zanjing
    Liu, Guangwang
    Tang, Tingting
    Lin, Zhen
    Zheng, Minghao
    Qin, An
    Dai, Kerong
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2013, 430 (03) : 951 - 956
  • [35] WSS25, a sulfated polysaccharide, inhibits RANKL-induced mouse osteoclast formation by blocking SMAD/ID1 signaling
    Chen, Cheng
    Qin, Yi
    Fang, Jian-ping
    Ni, Xin-yan
    Yao, Jian
    Wang, Hai-ying
    Ding, Kan
    ACTA PHARMACOLOGICA SINICA, 2015, 36 (09) : 1053 - 1064
  • [36] IL-33 inhibits RANKL-induced osteoclast formation through the regulation of Blimp-1 and IRF-8 expression
    Kiyomiya, Hiroyasu
    Ariyoshi, Wataru
    Okinaga, Toshinori
    Kaneuji, Takeshi
    Mitsugi, Sho
    Sakurai, Takuma
    Habu, Manabu
    Yoshioka, Izumi
    Tominaga, Kazuhiro
    Nishihara, Tatsuji
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2015, 460 (02) : 320 - 326
  • [37] WSS25, a sulfated polysaccharide, inhibits RANKL-induced mouse osteoclast formation by blocking SMAD/ID1 signaling
    Cheng Chen
    Yi Qin
    Jian-ping Fang
    Xin-yan Ni
    Jian Yao
    Hai-ying Wang
    Kan Ding
    Acta Pharmacologica Sinica, 2015, 36 : 1053 - 1064
  • [38] Montelukast inhibits RANKL-induced osteoclast formation and bone loss via CysLTR1 and P2Y12
    Kang, Ju-Hee
    Lim, Hyungsik
    Lee, Dong-Seok
    Yim, Mijung
    MOLECULAR MEDICINE REPORTS, 2018, 18 (02) : 2387 - 2398
  • [39] FIBROBLAST-LIKE SYNOVIOCYTES INHIBIT TNF- AND RANKL-INDUCED HUMAN OSTEOCLAST PRECURSOR DIFFERENTIATION FOLLOWING EXPOSURE TO IL-1BETA
    Harvey, B. P.
    Syed, F.
    Kaymakcalan, Z.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 71 : 162 - 163
  • [40] Active vitamin D reduces c-Fos and Fra-1 proteins in osteoclast precursors, and inhibits RANKL-induced osteoclastogenesis in vivo and in vitro.
    Takasu, H
    Okazaki, M
    Sugita, A
    Kubota, N
    Ogata, E
    Ikeda, K
    Uchiyama, Y
    JOURNAL OF BONE AND MINERAL RESEARCH, 2002, 17 : S291 - S291
12345